Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
GLOBETECH PUBLISHING
FOCUS DIAGNOSTICS, INC.

Genetic Root Identified For Early-Onset Prostate Cancer

By Labmedica International staff writers
Posted on 28 Feb 2013
Early-onset prostate cancer (EOPC) requires early diagnosis and definitive treatment due to the long life expectancy of younger patients and their higher risk of dying from the disease.

Deep sequencing-based genomics analysis has been used to compare the genomic alteration landscapes of EOPC patients with those with the classical elderly-onset prostate cancer.

Scientists at the European Molecular Biology Laboratory (EMBL; Heidelberg, Germany) sequenced the entire genetic code of cells in 11 tumors from EOPC patients, comparing it with the code in tumors from seven patients with elderly-onset prostate cancer. They used these genomics data, together with a large-scale tissue microarray (TMA)-based validation platform, to pinpoint molecular features linked with early disease occurrence.

The investigators found that the receptor that binds testosterone, called the androgen receptor, is very active in tumors from young patients, causing a number of genes to rearrange and become cancer promoting. The genomes of elderly prostate cancer patients primarily showed abnormalities that were not caused by the androgen receptor's activity. Data from more than 10,000 additional patients showed that androgen receptor activity and corresponding gene rearrangements were indeed higher in younger patients.

Jan Korbel, PhD, the cosenior author of the study, said, "It's been unclear whether prostate cancer in the young is explainable by a different mechanism than prostate cancer in the elderly. Our study implicates a different cause of disease in young patients. Interestingly, young men have generally higher testosterone levels than elderly men, which raises the question of whether high physiological levels of testosterone in young men may be linked with early-onset prostate cancer, a question that we are keen to address in the future." The authors concluded that their findings demonstrate striking age-dependent differences in the mechanistic landscapes of structural genomic alterations in a common cancer. The study was published on February 11, 2013, in the journal Cancer Cell.

Related Links:

European Molecular Biology Laboratory




DiagCor Bioscience
Sekisui Diagnostics
VIRCELL
comments powered by Disqus
Life Technologies

Channels

Immunology

view channel
Image: The fluorescence-activated cell sorting FACSCanto II flow cytometer (Photo courtesy of BD Biosystems).

Flow Cytometry Detects Lymphoproliferative Disorders in Fluid Specimens

Immunophenotypic analysis of hematopoietic cell populations by flow cytometry has emerged as a useful ancillary study in the diagnostic evaluation of serous effusions and cerebrospinal fluids (CSFs).... Read more

Lab Tech.

view channel
Image: A technical breakthrough for DNA imaging has been achieved that should quicken diagnosis of diseases for which analysis of DNA from single-cells is critical, such as early stage cancers and various pre-natal conditions (Photo courtesy of McGill University and Génome Québec Innovation Center).

Breakthrough DNA Analysis Technology to Hasten Problem Diagnosis

Researchers have achieved a technical breakthrough that should result in speedier diagnosis of diseases for which analysis of DNA from single-cells is critical, such as early stage cancers and various... Read more

Industry News

view channel

Most IVD Sector Companies Look Outside the EU and USA for Growth

Kalorama Information (New York City, NY, USA) has now published the 9th edition of its biennial market research report “Worldwide Market for In Vitro Diagnostics,” revealing estimates from its survey of the in vitro diagnostics (IVD) industry – presenting the trends, technologies, customer needs, and major suppliers with... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.